Some providers said systems don’t have enough supplies on hand while others said staffing shortages are limiting the ability to administer the treatment. Other providers, like Ametia Health, which has 19 hospitals in Illinois, have been able to give the treatment to any qualifying patients thus far.
Between Nov. 29 and Dec. 12, the state allocated 8,638 courses of monoclonal antibodies to more than 100 providers, with Innovative Care receiving nearly 500 for its two locations, according to a recent health department memo to providers.
The Tribune report said the state takes into consideration which areas are in greatest need as well as how much a facility has been using when deciding where to send treatments during shortages.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
